bioRxiv Science⌕ Search

Biology subjects

Drysdale, E.

Publications and source records attributed to Drysdale, E..

2 recordsLinked to original sources

A multitask neural network trained on embeddings from ESMFold can accurately rank order clinical outcomes for different cystic fibrosis mutations

Advancements in AI-based protein structure prediction have opened new research avenues in computational biology. Previous work has shown mixed results when the predicted 3D structure or model embeddings have been used as features for predicting phenotypes. Many existing tools which predict the pathogenicity of variants (e.g. SIFT 4G, Polyphen-2, REVEL, LYRUS) have incorporated structural protein features, but have shown mixed success when applied to mutations on the CFTR gene. This paper explores whether embeddings from the ESM-Fold model, which predicts the 3D structure of a protein from an amino acid sequence, can be used to predict clinical outcomes for different Cystic Fibrosis (CF) genotypes found in the CFTR2 database. A neural network model trained on these embeddings is able to obtain both non-trivial and statistically significant correlations on CF-related phenotypes (sweat chloride, pancreatic insufficiency, and infection rates). Overall, AI-based protein structure prediction models show a promising ability to assess the relative severity of CFTR-based mutations on key phenotypic outcomes associated with CF. The entire processing and analysis pipeline for this work can be found at this repo.

genetics↗

The Telomere Length Landscape of Localized Prostate Cancer

Replicative immortality is a hallmark of cancer, and can be achieved through telomere lengthening and maintenance. We report telomere lengths (TLs) of 392 localized prostate cancer tumours and characterize their relationship to genomic, transcriptomic and proteomic features. Shorter tumour TLs were associated with elevated genomic instability, including single-nucleotide variants, indels and structural variants. Genes involved in cell proliferation and signaling were correlated with tumour TL at all levels of the central dogma. TL was also associated with multiple clinical features of a tumour. Longer TLs in non-tumour samples were associated with a lower rate of biochemical relapse after definitive local therapy. Our analysis integrates multi-omics data to illuminate the relationship of specific genomic alterations in a tumour and TL in prostate cancer. Although the role of telomere length in cancer has been well studied, its association to genomic features is less well known. We describe the multi-level integration of telomere length, genomics, transcriptomics and proteomics in localized prostate cancer. Patient Summary We examined the association between telomere length and multiple omics-level data in prostate cancer. We observed that traditional telomere mutations are rare in prostate cancer and that telomere length is associated with multiple measure of genomic instability.

genomics↗